Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Untangling the complexity of opioid receptor function
Rita J. Valentino, Nora D. Volkow
Neuropsychopharmacology (2018) Vol. 43, Iss. 13, pp. 2514-2520
Open Access | Times Cited: 259

Showing 1-25 of 259 citing articles:

Structure-Based Virtual Screening for Ligands of G Protein–Coupled Receptors: What Can Molecular Docking Do for You?
Flavio Ballante, Albert J. Kooistra, Stefanie Kampen, et al.
Pharmacological Reviews (2021) Vol. 73, Iss. 4, pp. 1698-1736
Open Access | Times Cited: 104
Piperidine Derivatives: Recent Advances in Synthesis and Pharmacological Applications
Nikita A. Frolov, A. N. Vereshchagin
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2937-2937
Open Access | Times Cited: 79
Elucidating the active δ-opioid receptor crystal structure with peptide and small-molecule agonists
Tobias Claff, Jing Yu, Véronique Blais, et al.
Science Advances (2019) Vol. 5, Iss. 11
Open Access | Times Cited: 103
Opioid-Associated Out-of-Hospital Cardiac Arrest: Distinctive Clinical Features and Implications for Health Care and Public Responses: A Scientific Statement From the American Heart Association
Cameron Dezfulian, Aaron Orkin, Bradley A. Maron, et al.
Circulation (2021) Vol. 143, Iss. 16
Open Access | Times Cited: 95
Full Opioid Agonists and Tramadol: Pharmacological and Clinical Considerations
Amber N. Edinoff, Leah A. Kaplan, Sami Khan, et al.
Anesthesiology and Pain Medicine (2021) Vol. 11, Iss. 4
Open Access | Times Cited: 65
The Kappa Opioid Receptor: A Promising Therapeutic Target for Multiple Pathologies
Martin L. Dalefield, Brittany Scouller, Rabia Bibi, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 60
Positive allosteric modulation of the mu-opioid receptor produces analgesia with reduced side effects
Ram Kandasamy, Todd M. Hillhouse, Kathryn E. Livingston, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 16
Open Access | Times Cited: 56
Endogenous opioid systems alterations in pain and opioid use disorder
Jessica A. Higginbotham, Tamara Markovic, Nicolas Massaly, et al.
Frontiers in Systems Neuroscience (2022) Vol. 16
Open Access | Times Cited: 43
Pharmacological Methods of Pain Management: Narrative Review of Medication Used
Nasser M. Alorfi
International Journal of General Medicine (2023) Vol. Volume 16, pp. 3247-3256
Open Access | Times Cited: 39
Interaction of neurotransmitters and neurochemicals with lymphocytes
Daniel Kerage, Erica K. Sloan, Stephen R. Mattarollo, et al.
Journal of Neuroimmunology (2019) Vol. 332, pp. 99-111
Open Access | Times Cited: 66
Interruption of continuous opioid exposure exacerbates drug-evoked adaptations in the mesolimbic dopamine system
Emilia M. Lefevre, Marc T. Pisansky, Carlee Toddes, et al.
Neuropsychopharmacology (2020) Vol. 45, Iss. 11, pp. 1781-1792
Open Access | Times Cited: 65
Microglia Express Mu Opioid Receptor: Insights From Transcriptomics and Fluorescent Reporter Mice
Tando Maduna, Emilie Audouard, Doulaye Dembélé, et al.
Frontiers in Psychiatry (2019) Vol. 9
Open Access | Times Cited: 64
Epidemiology of the U.S. opioid crisis: the importance of the vector
Wilson M. Compton, Christopher M. Jones
Annals of the New York Academy of Sciences (2019) Vol. 1451, Iss. 1, pp. 130-143
Open Access | Times Cited: 59
New viral‐genetic mapping uncovers an enrichment of corticotropin‐releasing hormone‐expressing neuronal inputs to the nucleus accumbens from stress‐related brain regions
Christy A. Itoga, Yuncai Chen, Cameron Fateri, et al.
The Journal of Comparative Neurology (2019) Vol. 527, Iss. 15, pp. 2474-2487
Open Access | Times Cited: 57
Assessment of Biased Agonism among Distinct Synthetic Cannabinoid Receptor Agonist Scaffolds
Elise Wouters, Jolien Walraed, Michael J. Robertson, et al.
ACS Pharmacology & Translational Science (2019) Vol. 3, Iss. 2, pp. 285-295
Open Access | Times Cited: 56
Current strategies toward safer mu opioid receptor drugs for pain management
Aliza T. Ehrlich, Brigitte L. Kieffer, Emmanuel Darcq
Expert Opinion on Therapeutic Targets (2019) Vol. 23, Iss. 4, pp. 315-326
Open Access | Times Cited: 55
The anterior cingulate cortex as a key locus of ketamine’s antidepressant action
Laith Alexander, Luke A. Jelen, Mitul A. Mehta, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 127, pp. 531-554
Open Access | Times Cited: 53
Overlap in the neural circuitry and molecular mechanisms underlying ketamine abuse and its use as an antidepressant
Saurabh S. Kokane, Ross J. Armant, Carlos A. Bolaños‐Guzmán, et al.
Behavioural Brain Research (2020) Vol. 384, pp. 112548-112548
Open Access | Times Cited: 51
Mu opioid receptor in microglia contributes to morphine analgesic tolerance, hyperalgesia, and withdrawal in mice
David J. Reiss, Tando Maduna, Hervé Maurin, et al.
Journal of Neuroscience Research (2020) Vol. 100, Iss. 1, pp. 203-219
Open Access | Times Cited: 50
Neurodevelopmental origins of substance use disorders: Evidence from animal models of early‐life adversity and addiction
S Levis, Tallie Z. Baram, Stephen V. Mahler
European Journal of Neuroscience (2021) Vol. 55, Iss. 9-10, pp. 2170-2195
Open Access | Times Cited: 49
Ketamine as a therapeutic agent for depression and pain: mechanisms and evidence
Subha Subramanian, Simon Haroutounian, Ben Julian A. Palanca, et al.
Journal of the Neurological Sciences (2022) Vol. 434, pp. 120152-120152
Closed Access | Times Cited: 34
Opioid-driven disruption of the septal complex reveals a role for neurotensin-expressing neurons in withdrawal
Rhiana C. Simon, Weston Fleming, P. Senthilkumar, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 8
Opioid-induced endocrinopathies
Athanasios Fountas, Stan Van Uum, Niki Karavitaki
The Lancet Diabetes & Endocrinology (2019) Vol. 8, Iss. 1, pp. 68-80
Open Access | Times Cited: 46
The Pharmacology of Visual Hallucinations in Synucleinopathies
Mirella Russo, Claudia Carrarini, Fedele Dono, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 46
Neurological correlates of brain reward circuitry linked to opioid use disorder (OUD): Do homo sapiens acquire or have a reward deficiency syndrome?
Mark S. Gold, David Baron, Abdalla Bowirrat, et al.
Journal of the Neurological Sciences (2020) Vol. 418, pp. 117137-117137
Open Access | Times Cited: 46
Page 1 - Next Page

Scroll to top